- Report
- August 2025
- 165 Pages
Global
From €1971EUR$2,250USD£1,701GBP
- Report
- January 2026
- 191 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- February 2026
- 554 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- September 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- September 2025
- 136 Pages
Global
From €3504EUR$3,999USD£3,023GBP
- Report
- July 2025
- 210 Pages
Global
From €4376EUR$4,995USD£3,777GBP
- Report
- October 2025
- 160 Pages
Global
From €3461EUR$3,950USD£2,986GBP
- Report
- January 2026
- 198 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- August 2025
- 194 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- February 2026
- 286 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- September 2025
- 150 Pages
Global
From €3373EUR$3,850USD£2,911GBP
€4249EUR$4,850USD£3,667GBP
- Report
- August 2025
- 150 Pages
Global
From €3373EUR$3,850USD£2,911GBP
€4249EUR$4,850USD£3,667GBP
- Report
- September 2025
- 450 Pages
Global
From €4337EUR$4,950USD£3,742GBP
- Report
- April 2025
- 387 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- May 2025
- 100 Pages
Global
From €5213EUR$5,950USD£4,499GBP
- Report
- May 2025
- 200 Pages
Global
From €2182EUR$2,490USD£1,883GBP
- Report
- August 2025
- 199 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- August 2025
- 188 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- August 2025
- 192 Pages
Global
From €3451EUR$3,939USD£2,978GBP
- Report
- February 2026
- 383 Pages
Global
From €5125EUR$5,850USD£4,423GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more